228 related articles for article (PubMed ID: 11557264)
21. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
Winsauer PJ; Moerschbaecher JM
Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126
[TBL] [Abstract][Full Text] [Related]
22. Role of serotonin1A receptors on the modulation of rat spinal mono-synaptic reflexes in vitro.
Hedo G; Ajubita M; Lopez-Garcia JA
Neurosci Lett; 2002 Dec; 334(1):41-4. PubMed ID: 12431771
[TBL] [Abstract][Full Text] [Related]
23. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.
Maura G; Marcoli M; Pepicelli O; Rosu C; Viola C; Raiteri M
Br J Pharmacol; 2000 Aug; 130(8):1853-8. PubMed ID: 10952674
[TBL] [Abstract][Full Text] [Related]
24. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
[TBL] [Abstract][Full Text] [Related]
26. The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors.
Calcagno E; Carli M; Invernizzi RW
J Neurochem; 2006 Feb; 96(3):853-60. PubMed ID: 16405507
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
28. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule.
Ho MY; Body S; Kheramin S; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2003 May; 167(2):137-44. PubMed ID: 12655461
[TBL] [Abstract][Full Text] [Related]
29. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
Hasegawa Y; Ono H
Brain Res; 1996 Oct; 738(1):158-61. PubMed ID: 8949941
[TBL] [Abstract][Full Text] [Related]
30. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C
Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536
[TBL] [Abstract][Full Text] [Related]
31. The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies.
Roberts C; Allen L; Langmead CJ; Hagan JJ; Middlemiss DN; Price GW
Br J Pharmacol; 2001 Apr; 132(7):1574-80. PubMed ID: 11264252
[TBL] [Abstract][Full Text] [Related]
32. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones.
Craven R; Grahame-Smith D; Newberry N
Eur J Pharmacol; 1994 Dec; 271(1):R1-3. PubMed ID: 7698189
[TBL] [Abstract][Full Text] [Related]
33. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
[TBL] [Abstract][Full Text] [Related]
34. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
35. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
[TBL] [Abstract][Full Text] [Related]
36. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
37. A novel 5-HT receptor or a combination of 5-HT receptor subtypes may mediate depression of a spinal monosynaptic reflex in vitro.
Crick H; Manuel NA; Wallis DI
Neuropharmacology; 1994 Jul; 33(7):897-904. PubMed ID: 7969810
[TBL] [Abstract][Full Text] [Related]
38. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
Egashira N; Matsuda T; Koushi E; Higashihara F; Mishima K; Chidori S; Hasebe N; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 Jul; 589(1-3):117-21. PubMed ID: 18565508
[TBL] [Abstract][Full Text] [Related]
39. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
40. Role of 5-HT(1A) and 5-HT(7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation.
Meneses A; Terrón JA
Behav Brain Res; 2001 Jun; 121(1-2):21-8. PubMed ID: 11275281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
